These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21300664)

  • 1. Sympathetic activation in chronic kidney disease: out of the shadow.
    Schlaich MP
    Hypertension; 2011 Apr; 57(4):683-5. PubMed ID: 21300664
    [No Abstract]   [Full Text] [Related]  

  • 2. Sympathetic activation in chronic renal failure.
    Schlaich MP; Socratous F; Hennebry S; Eikelis N; Lambert EA; Straznicky N; Esler MD; Lambert GW
    J Am Soc Nephrol; 2009 May; 20(5):933-9. PubMed ID: 18799718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contemporary diagnosis of increased sympathetic activity: the ups and downs].
    Luciak M
    Pol Arch Med Wewn; 2002 Apr; 107(4):345-7. PubMed ID: 12189926
    [No Abstract]   [Full Text] [Related]  

  • 4. Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia?
    Rump LC; Amann K; Orth S; Ritz E
    Nephrol Dial Transplant; 2000 Nov; 15(11):1735-8. PubMed ID: 11071955
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of sympathetic overactivity in patients with chronic renal failure: a role for chemoreflex activation?
    Hausberg M; Grassi G
    J Hypertens; 2007 Jan; 25(1):47-9. PubMed ID: 17143171
    [No Abstract]   [Full Text] [Related]  

  • 6. Sympathetic hyperactivity in chronic kidney disease.
    Blankestijn PJ
    Nephrol Dial Transplant; 2004 Jun; 19(6):1354-7. PubMed ID: 15069180
    [No Abstract]   [Full Text] [Related]  

  • 7. Excessive sympathetic activation in heart failure with chronic renal failure: role of chemoreflex activation.
    Despas F; Detis N; Dumonteil N; Labrunee M; Bellon B; Franchitto N; Galinier M; Senard JM; Pathak A
    J Hypertens; 2009 Sep; 27(9):1849-54. PubMed ID: 19542895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing resting skin sympathetic nerve activity between groups: caution needed.
    Young CN; Keller DM; Crandall CG; Fadel PJ
    J Appl Physiol (1985); 2009 May; 106(5):1751-2; author reply 1753. PubMed ID: 19414629
    [No Abstract]   [Full Text] [Related]  

  • 9. Sympathetic skin response in chronic renal failure and correlation with sensorimotor neuropathy.
    Dellantonio R; Paladini D; Carletti P; Sirocchi G; Angèleri VA
    Funct Neurol; 1989; 4(2):173-5. PubMed ID: 2737506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early sympathetic activation in the initial clinical stages of chronic renal failure.
    Grassi G; Quarti-Trevano F; Seravalle G; Arenare F; Volpe M; Furiani S; Dell'Oro R; Mancia G
    Hypertension; 2011 Apr; 57(4):846-51. PubMed ID: 21300663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of moxonidine on sympathetic nerve activity in patients with end-stage renal disease.
    Hausberg M; Tokmak F; Pavenstädt H; Krämer BK; Rump LC
    J Hypertens; 2010 Sep; 28(9):1920-7. PubMed ID: 20634720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathetic nervous system function and dysfunction in chronic hemodialysis patients.
    Rubinger D; Backenroth R; Sapoznikov D
    Semin Dial; 2013; 26(3):333-43. PubMed ID: 23627490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [State of the sympathetic-adrenal system and aldosterone excretion in children with urolithiasis, pyelonephritis and chronic renal insufficiency].
    Abdullaev KI; Mamedova IaA
    Urol Nefrol (Mosk); 1977; (6):21-4. PubMed ID: 929779
    [No Abstract]   [Full Text] [Related]  

  • 14. The sympathetic nervous system and hypertension: recent developments.
    DiBona GF
    Hypertension; 2004 Feb; 43(2):147-50. PubMed ID: 14707153
    [No Abstract]   [Full Text] [Related]  

  • 15. Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure.
    Hering D; Zdrojewski Z; Król E; Kara T; Kucharska W; Somers VK; Rutkowski B; Narkiewicz K
    J Hypertens; 2007 Jan; 25(1):157-61. PubMed ID: 17143187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic overactivity in patients with chronic renal failure.
    Converse RL; Jacobsen TN; Toto RD; Jost CM; Cosentino F; Fouad-Tarazi F; Victor RG
    N Engl J Med; 1992 Dec; 327(27):1912-8. PubMed ID: 1454086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathetic overactivity in uremia.
    Ksiazek A; Załuska W
    J Ren Nutr; 2008 Jan; 18(1):118-21. PubMed ID: 18089457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of sympathetic nervous activity in renal injury and end-stage renal disease.
    Masuo K; Lambert GW; Esler MD; Rakugi H; Ogihara T; Schlaich MP
    Hypertens Res; 2010 Jun; 33(6):521-8. PubMed ID: 20339374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antihypertensive therapy in renal failure].
    Mayer G
    Acta Med Austriaca; 1995; 22(3):51-3. PubMed ID: 8571752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.
    Schlaich MP; Bart B; Hering D; Walton A; Marusic P; Mahfoud F; Böhm M; Lambert EA; Krum H; Sobotka PA; Schmieder RE; Ika-Sari C; Eikelis N; Straznicky N; Lambert GW; Esler MD
    Int J Cardiol; 2013 Oct; 168(3):2214-20. PubMed ID: 23453868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.